Accrued expenses consisted of the following as of March 31, 2025 and December 31, 2024 (in thousands):
March 31,
December 31,
2025
2024
Accrued research and development
$
30,000
22,782
Accrued royalties
6,007
7,147
Accrued payroll liabilities
19,626
40,888
Product revenue reserves
38,904
45,145
Commercial costs
17,778
20,610
Other
3,831
3,612
Total
116,146
140,184
No definition available.
Tabular disclosure of the components of accrued liabilities.